Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 22

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 22
---
554 |
| G. Tilton   | ​ | ​            | 155,000 | ​ | ​          | 214,818 | ​ | ​      | 0 | ​ | ​             |       0 | ​ | ​            | 50,009 | ​ | ​     | 419,827 |
| F. Waddell  | ​ | ​            | 140,000 | ​ | ​          | 214,818 | ​ | ​      | 0 | ​ | ​             |       0 | ​ | ​            | 55,436 | ​ | ​     | 410,254 |

| (1) | Under the Non-Employee Directors’ Fee Plan as in effect during 2024, non-employee directors earned $120,000 per year for service as a director and $25,000 per year for service as a chair of a Board committee, other than the chair of the audit committee. The chair of the audit committee received $30,000 per year for service as chair of that committee and the other members of the audit committee received $10,000 per year as a committee member. Mr. Tilton received $25,000 as the Lead Independent Director until July 1, 2024 at which point Ms. Austin was appointed to that role. Ms. Austin received $25,000 as Lead Independent Director from July through December. The non-employee director and committee fees are earned monthly for each calendar month or portion thereof that the director holds the position, excluding the month in which the director is first elected to the position. |

Fees earned under the AbbVie Non-Employee Directors’ Fee Plan are, at the director’s election, paid currently in cash, delivered in the form of vested non-qualified stock options (based on an independent appraisal of their fair value), deferred (as an unfunded AbbVie obligation), or paid currently into an individual grantor trust established by an eligible director. The distribution of deferred fees and amounts held in a director’s grantor trust generally commences at the later of when the director reaches age 65 or upon retirement from the Board of Directors. Deferred fees and fees deposited in a trust may be credited to a stock equivalent account that earns the same return as if the fees were invested in AbbVie stock or to a guaranteed interest account. If necessary, AbbVie contributes funds to a director’s trust so that as of year-end the stock equivalent account balance (net of taxes) is not less than